cd33 car-t cells
Cell therapyexperimental
Clinical trial activity
15 trials · 20 clinical orgs · 0 marketing orgs
Phase 1
14
Phase 2
7
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2013 (NCT01864902)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Myeloid cell surface antigen CD33Immunity, passive
CD33 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- anti-cd33-car-t cells
- cd33 car-t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07026942 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2026 | Ohio State University |
| NCT06917105 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2025 | Government of China, Huazhong University of Science and Technology |
| NCT06762132 | Early Phase 1 (Phase 1) | Jan 10, 2025 | Yake Biotechnology Ltd., Zhejiang University |
| NCT06326021 | Phase 1 | Aug 1, 2024 | Government of China |
| NCT06420063 | Phase 1/Phase 2 (Phase 2) | Jul 10, 2024 | Essen Biotech |
| NCT05672147 | Phase 1 | Dec 28, 2023 | City of Hope National Medical Center, National Cancer Institute (NCI) |
| NCT05995041 | Phase 1 | Oct 31, 2023 | Shenzhen Geno-Immune Medical Institute |
| NCT05473221 | Phase 1 | Aug 2, 2022 | Zhejiang University |
| NCT05445765 | Phase 1 | Jul 1, 2022 | Hebei University, iCell Gene Therapeutics |
| NCT03971799 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2019 | Center for International Blood and Marrow Transplant Research, National Cancer Institute (NCI), National Marrow Donor Program, St. Baldrick's Foundation, University of Pennsylvania |
| NCT04010877 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2019 | Shenzhen Geno-Immune Medical Institute |
| NCT03473457 | N/A | Apr 1, 2018 | Southern Medical University, Sun Yat-Sen University |
| NCT03126864 | Phase 1 | Jun 1, 2017 | Intrexon, University of Texas at Houston |
| NCT02958397 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2016 | People's Liberation Army of China |
| NCT01864902 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2013 | People's Liberation Army of China |
Showing 15 of 15 trials
Page 1 / 1
Organizations
Research & Development (20)
20 organizations
Page 1 / 1